期刊文献+

血清miR-29c和miR-720表达在脑胶质瘤患者检测中的意义 被引量:4

Significance of miR-29c and miR-720 expression in brain glioma
原文传递
导出
摘要 目的观察血清miR-29c和miR-720表达在脑胶质瘤患者检测中的意义及其对预后的影响。方法选择术后病理证实为脑胶质瘤患者95例为脑胶质瘤组,35例健康体检者为对照组。用q RT-PCR的方法检测各组血清miR-29c和miR-720表达,观察脑胶质瘤组和健康对照组的miR-29c和miR-720表达水平变化,并观察脑胶质瘤患者血清miR-29c和miR-720表达水平与年龄,性别,肿瘤直径,病理类型,肿瘤分化程度,KPS评分和肿瘤部位的关系,手术前后miR-29c和miR-720表达水平的变化,及其高表达miR-29c和miR-720水平对1年生存率的影响。结果脑胶质瘤组患者血清miR-29c相对表达明显低于健康对照组(t=8.634,P<0.01),手术后脑胶质瘤患者血清miR-29c表达量明显较治疗前升高(t=9.448,P<0.01);而miR-720脑胶质瘤的相对表达量明显高于对照组(t=14.035,P<0.01),手术后患者的miR-720表达水平明显较治疗前明显降低(t=13.462,P<0.01)。脑胶质瘤患者血清miR-29c表达水平随着肿瘤分化程度升高而升高(P<0.01),血清miR-720相对表达水平随着肿瘤分化程度升高而降低(P<0.01)。血清miR-29c和miR-720相对表达水平与年龄,性别,肿瘤直径,病理类型,KPS评分和肿瘤部位无明显相关性(P>0.05)。血清miR-29c高表达为42例,其1年生存率为95.24%(40/42),低表达组53例,其1年生存率为77.36%(41/53),高表达组明显高于低表达组(χ2=4.623,P<0.05)。而血清miR-720高表达组51例,其1年生存率为76.47%(39/51),低表达组44例,其1年生存率为95.45%(42/44)例,高表达组明显低于低表达组(χ2=5.348,P<0.05)。结论血清联合检测miR-29c和miR-720表达在脑胶质瘤诊断和预后判断具有重要价值,可作为一种诊断和病情评估的重要指标。 Objective To investigate the significance of miR-29c and miR-720 expression in the diagnosis of brain glioma and their impacts on prognosis. Methods A total of 95 patients with pathologically confirmed brain glioma in our hospital were enrolled in this study. Thirty-five healthy individuals served as healthy control. The serum expressionof miR-29c and miR-720 was detected by qRT-PCR in each group. And the results were compared between the brain glioma group and the healthy control. The correlation of the expression level swas analyzed with age,gender,tumor size,histological type,tumor differentiation,Karnofsky performance scale(KPS)score,and tumor location. The expression levels were also observed before and after surgery,and their impact on 1-year survival rate was analyzed. Results The serum level of miR-29c was significantly lower in the brain glioma group than those in healthy control group(t=8.634,P〈0.01),and was elevated after surgery when compared with the level before treatment(t=9.448,P〈0.01).The expression level of miR-720 was obviously higher in the glioma patients than the healthy controls(t=14.035,P〈0.01),and it was decreased after surgery(t=13.462,P〈0.01). The serum level of miR-29c was significantly increased with the increase of tumor differentiation(P〈0.01),while,that of miR-720 was decreased with the increase of tumor differentiation(P〈0.01). There were no significantly correlations of the levels of miR-29c and miR-720 with age,gender,tumor size,histological type,KPS score and tumor location(P〉0.05). The 1-year survival rate was 95.24%(40/42)for the 42 cases with high level of miR-29c,and was 77.36%(41/53)in the 53 casesof low expression,with that of the former group significantly higher than the later(χ2=4.623,P〈0.05). And the 1-year survival rate was 76.47%(39/51)for the 51 cases with high miR-720 expression,and 95.45%(42/44)in the 44 cases with low expression,with that of the high expression group significantly lower than the low expression group(Chi square=5.348,P〈0.05). Conclusion Combined detection of serum miR-29c and miR-720 is of important value in the diagnosis and prognosis of brain glioma,and should be used as an important indicator for diagnosis and prognosis.
出处 《中国热带医学》 CAS 2016年第8期818-821,共4页 China Tropical Medicine
关键词 脑胶质瘤 微小RNA 诊断 预后 Glioma Micro RNA Diagnosis Prognosis
  • 相关文献

参考文献12

  • 1郭珊珊,朱仲玲,徐辉,丁凤霞,王国成,赵敏,阎昭.替莫唑胺酯对脑胶质瘤的作用及其机制研究[J].中国临床药理学杂志,2015,31(13):1271-1275. 被引量:16
  • 2LANDI D, MORENO V, GUINO E, et al. Polymorphisms affecting micro-RNA regulation and associated with the risk of dietary-related cancers: a review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorectal cancer[J]. Mutat Res,2011,717 (1-2):109-115.
  • 3代大伟,田恒力,陈鑫.miR-29c对脑胶质瘤U251细胞生物学活性的影响[J].中国微侵袭神经外科杂志,2012,17(6):277-279. 被引量:2
  • 4周学,杜宜兰,金萍,马飞.癌症相关microRNA与靶基因的生物信息学分析[J].遗传,2015,37(9):855-864. 被引量:25
  • 5何涵,石羽,李青原,史家玮,李凌.miR-98对肝癌细胞增殖和侵袭能力的影响[J].中国热带医学,2014,14(1):16-19. 被引量:3
  • 6LIU N, TANG L L, SUN Y, et al. MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma[J]. Cancer Lett,2013,329(2): 181 - 188.
  • 7LIU L, YE J X, QIN Y Z, et al. Evaluation of miR-29c, miR- 124, miR-135a and miR-148a in predicting lymph node metastasis and tumor stage of gastric cancer[J]. Int J Clin Exp Med,2015,8(12): 22227-22236.
  • 8CRISTOBAL I, MADOZ-GURPIDE J, MANSO R, et al. MiR-29c downregulation contributes to metastatic progression in colorectal cancer[J]. Ann Oncol,2015,26(10):2199-2200.
  • 9YU Y, WANG Y, NIU Y, et al. Leukemia inhibitory factor attenuates renal fibrosis through Stat3-miR-29c[J]. Am J Physiol Renal Physiol, 2015,309(7):595-603.
  • 10NONAKA R, MIYAKE Y, HATA T, et al. Circulating miR-103 and miR-720 as novel serum biomarkers for patients with colorectal cancer[J]. Int J Oncol,2015,47(3): 1097-1102.

二级参考文献59

  • 1Mehmet Coskun,Jacob Tveiten Bjerrum,Jakob Benedict Seidelin,Jesper Thorvald Troelsen,JΦrgen Olsen,Ole Haagen Nielsen.miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis[J].World Journal of Gastroenterology,2013,19(27):4289-4299. 被引量:20
  • 2Barrel DP. MicroRNAs: genomics, biogenesis, mechanism, and function [J]. Cell, 2004, 116(2): 281-297.
  • 3Chiang CW, Huang Y, Leong KW, et ol. PKCet mediated induction of miR-101 in human hepatoma HepG2 cells [J]. J Biomed Sci, 2010, 17(1): 35.
  • 4Yan LX, Huang XF, Shao Q, et td. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis [J]. RNA, 2008, 14(11): 2348-2360.
  • 5Gao W, Shen H, Liu L, et td. MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis [J]. J Cancer Res Clin Oncol, 2011,137(4): 557-566.
  • 6Mott JL Kobayashi S, Bronk SF, et al. miR-29 regulates Mcl-1 protein expression and apoptosis [J]. Oncogene, 2007, 26(42): 6133-6140.
  • 7Chen QR, Yu LR, Tsang P, et td. Systematic proteome ana- lysis identifies transcription factor YYI as a direct target of miR-34a [J]. J Proteome Res, 2011, 10(2): 479-487.
  • 8Wang H, Garzon R, Sun H, et ~d. NF-kappa B-YYI-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomy- osarcoma [J]. Cancer Cell, 2008, 14(5): 369-381.
  • 9吴易阳,李岭.MicroRNA与肿瘤相关的信号转导通路[J].遗传,2007,29(12):1419-1428. 被引量:12
  • 10Ramirez YP, Weatherbee JL, Wheelhouse RT, et al. Glioblastoma multiforme therapy and mechanisms of resistance[ J]. Pharmaceuti- cals (Basel), 2013,6 : 1475 - 1506.

共引文献48

同被引文献33

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部